Browsing by Author Selle, Frederic

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2017Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinicianreported incidence and severity of neurotoxicity in the ICON7 trialAsher, Rebecca; Beale, Philip; Kwok, John; Lee, Chee Khoon; Park, Susanna; Friedlander, Michael; Selle, Frederic; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: Medicine; NH&MRC Clinical Trials Centre; School of Medical Sciences: PhysiologyClinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinicianreported incidence and severity of neurotoxicity in the ICON7 trial, Annals of Oncology, vol.28, 11, 2017,pp 2733-2740
2014Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mullerian Adenosarcoma of the Female Genital TractRussell, Peter; Covens, Alan; Friedlander, Michael; Glasspool, Rosalind; Hilpert, Felix; Kristensen, Gunnar; Kwon, Sanghoon; Selle, Frederic; Small, William; Witteveen, Els; Central Clinical School: PathologyGynecologic Cancer InterGroup (GCIG) Consensus Review for Mullerian Adenosarcoma of the Female Genital Tract, International Journal Of Gynecological Cancer, vol.24, 9 Supplement 3, 2014,pp S78-S82
2017Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trialGebski, Val; et al, Various; Huzarski, Tomasz; Korach, Jacob; Ledermann, Jonathan; Oza, Amit M; Penson, Richard; Pignata, Sandro; Poveda, Andres; Pujade-Lauraine, Eric; Selle, Frederic; NH&MRC Clinical Trials CentreOlaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial, The Lancet Oncology, vol.18, 9, 2017,pp 1274-1284
2011A phase 3 trial of bevacizumab in ovarian cancerBeale, Philip; Carey, Mark; Cervantes, Andres; Collinson, Fiona; du Bois, Andreas; Essapen, Sharadah; Gourley, Charlie; Kimmig, R; Kristensen, Gunnar; Kurzeder, Christian; Ledermann, Jonathan; Lemenin, Arto; Lortholary, Alain; Mirza, Mansoor Raza; Oza, Amit; Parmar, M. K. B.; Perren, Timothy; Pfisterer, J.; Plante, Marie; Pujade-Lauraine, Eric; Qian, Wendi; Sehouli, Jalid; Selle, Frederic; Stahle, Anne; Stark, Dan; Swart, Ann Marie; Central Clinical School: MedicineA phase 3 trial of bevacizumab in ovarian cancer, New England Journal of Medicine, vol.365, 26, 2011,pp 2484-2496